It took 22 years, but Eli Manning has finally revealed the details behind one of the biggest draft controversies in NFL history. Back in 2004, the Chargers made Manning the No. 1 overall pick in the ...

Eli Lilly trades at $948.45 as of writing. Our 24/7 Wall St. price target is $1,085 over the next 12 months, implying roughly 14.3% upside. The recommendation is buy with a confidence level of 70%.

Xander Robin's fluorescent, stranger-than-fiction film follows a variety of American oddballs chasing grisly snake-hunting glory in the annual Florida Python Challenge. Where that doc series had the ...

The Braves are currently putting it all on the line in an attempt to pull off a rare series win in Los Angeles against the Dodgers. One of the biggest examples of that has been Eli White’s performance ...

Getting to a $2 trillion market cap from Eli Lilly’s current levels would require a compound annual growth rate of about 11.7% over the next seven years. That’s no easy feat, but if Eli Lilly can pull ...

The Florida Python Challenge brings out a fascinating cast of characters, all captured by the director Xander Robin’s camera. By Alissa Wilkinson When you purchase a ticket for an independently ...

Perhaps the most compelling moment of the 2026 NFL Draft came in the final round, when the Pittsburgh Steelers selected running back Eli Heidenreich and the pick was announced to the hometown crowd ...

There wasn't many questions surrounding the Philadelphia Eagles at tight end heading into the NFL Draft -- at least for the 2026 season. The Eagles did the best they could to run it back at tight end.

The Pittsburgh Steelers selected Mt. Lebanon graduate Eli Heidenreich in the seventh round of the 2026 NFL Draft. Heidenreich, a versatile player from the Naval Academy, was the 230th overall pick. At ...

Eli Heidenreich will begin his NFL career at home. The Navy football standout was drafted on Day 3 in the seventh round of the 2026 NFL Draft by the hometown Pittsburgh Steelers. He was selected as ...

Eli Lilly struck a deal to acquire Kelonia Therapeutics for $3.25 billion, the companies said Monday. The deal price could reach as much as $7 billion if Kelonia reaches certain clinical, regulatory ...